ECLP » Topics » Non-Vested Restricted Stock

These excerpts taken from the ECLP 10-K filed Feb 24, 2009.

Non-Vested Restricted Stock

Non-vested restricted stock is sometimes granted by the Company. The restrictions lapse on a pro rata basis over a specified period of time, generally four to five years. The grant date fair value per share of non-vested restricted stock, which is the stock price on the grant date, is expensed on a straight-line basis over the period during which the restrictions lapse. The shares represented by restricted stock awards are considered outstanding at the grant date, as the recipients are entitled to dividends and voting rights. A summary of restricted stock award activity for the period is presented below:

 

     Non-vested
Number of Shares
    Weighted
Average Grant -

Date Fair Value

Nonvested balance at January 1, 2008

   382,230     $ 18.28

Granted

   647,321     $ 20.33

Vested

   (194,250 )   $ 19.46

Forfeited

   (75,330 )   $ 20.92
        

Nonvested balance at December 31, 2008

   759,971     $ 19.47
        

 

77


Table of Contents

Compensation expense recorded for stock-based awards of restricted stock was $5.3 million, $2.3 million, and $2.6 million, for the years ended December 31, 2008, 2007 and 2006, respectively.

As of December 31, 2008, $11.9 million of total unrecognized compensation costs related to non-vested restricted awards is expected to be recognized over a weighted average period of 2.54 years. The fair value of shares vested in each of the years ended December 31, 2008, 2007 and 2006 was $3.2 million, $2.7 million and $6.0 million, respectively.

Non-Vested Restricted Stock

Non-vested restricted stock is sometimes granted by the Company. The restrictions lapse on a pro rata basis over a specified period of time, generally four to five years. The grant date fair value per share of non-vested restricted stock, which is the stock price on the grant date, is expensed on a straight-line basis over the period during which the restrictions lapse. The shares represented by restricted stock awards are considered outstanding at the grant date, as the recipients are entitled to dividends and voting rights. A summary of restricted stock award activity for the period is presented below:

 

     Non-vested
Number of Shares
    Weighted
Average Grant -

Date Fair Value

Nonvested balance at January 1, 2008

   382,230     $ 18.28

Granted

   647,321     $ 20.33

Vested

   (194,250 )   $ 19.46

Forfeited

   (75,330 )   $ 20.92
        

Nonvested balance at December 31, 2008

   759,971     $ 19.47
        

 

77


Table of Contents

Compensation expense recorded for stock-based awards of restricted stock was $5.3 million, $2.3 million, and $2.6 million, for the years ended December 31, 2008, 2007 and 2006, respectively.

As of December 31, 2008, $11.9 million of total unrecognized compensation costs related to non-vested restricted awards is expected to be recognized over a weighted average period of 2.54 years. The fair value of shares vested in each of the years ended December 31, 2008, 2007 and 2006 was $3.2 million, $2.7 million and $6.0 million, respectively.

Non-Vested Restricted Stock

Non-vested restricted stock is sometimes granted by the Company. The restrictions lapse on a pro rata basis over a specified period of time, generally
four to five years. The grant date fair value per share of non-vested restricted stock, which is the stock price on the grant date, is expensed on a straight-line basis over the period during which the restrictions lapse. The shares represented by
restricted stock awards are considered outstanding at the grant date, as the recipients are entitled to dividends and voting rights. A summary of restricted stock award activity for the period is presented below:

STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"> 











































































   Non-vested
Number of Shares
  Weighted
Average Grant -

SIZE="1">Date Fair Value

Nonvested balance at January 1, 2008

  382,230  $18.28

Granted

  647,321  $20.33

Vested

  (194,250) $19.46

Forfeited

  (75,330) $20.92
     

Nonvested balance at December 31, 2008

  759,971  $19.47
     

 


77







Table of Contents


Compensation expense recorded for stock-based awards of restricted stock was $5.3 million, $2.3 million, and $2.6
million, for the years ended December 31, 2008, 2007 and 2006, respectively.

As of December 31, 2008, $11.9 million of total unrecognized
compensation costs related to non-vested restricted awards is expected to be recognized over a weighted average period of 2.54 years. The fair value of shares vested in each of the years ended December 31, 2008, 2007 and 2006 was $3.2
million, $2.7 million and $6.0 million, respectively.

Non-Vested Restricted Stock

Non-vested restricted stock is sometimes granted by the Company. The restrictions lapse on a pro rata basis over a specified period of time, generally
four to five years. The grant date fair value per share of non-vested restricted stock, which is the stock price on the grant date, is expensed on a straight-line basis over the period during which the restrictions lapse. The shares represented by
restricted stock awards are considered outstanding at the grant date, as the recipients are entitled to dividends and voting rights. A summary of restricted stock award activity for the period is presented below:

STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"> 











































































   Non-vested
Number of Shares
  Weighted
Average Grant -

SIZE="1">Date Fair Value

Nonvested balance at January 1, 2008

  382,230  $18.28

Granted

  647,321  $20.33

Vested

  (194,250) $19.46

Forfeited

  (75,330) $20.92
     

Nonvested balance at December 31, 2008

  759,971  $19.47
     

 


77







Table of Contents


Compensation expense recorded for stock-based awards of restricted stock was $5.3 million, $2.3 million, and $2.6
million, for the years ended December 31, 2008, 2007 and 2006, respectively.

As of December 31, 2008, $11.9 million of total unrecognized
compensation costs related to non-vested restricted awards is expected to be recognized over a weighted average period of 2.54 years. The fair value of shares vested in each of the years ended December 31, 2008, 2007 and 2006 was $3.2
million, $2.7 million and $6.0 million, respectively.

This excerpt taken from the ECLP 10-Q filed Nov 10, 2008.

Non-Vested Restricted Stock

Non-vested restricted stock is sometimes granted by the Company. The restrictions lapse on a pro rata basis over a specified period of time, generally four to five years. The grant date fair value per share of non-vested restricted stock, which is the stock price on the grant date, is expensed on a straight-line basis over the period during which the restrictions lapse. The shares represented by restricted stock awards are considered outstanding at the grant date, as the recipients are entitled to dividends and voting rights. A summary of restricted stock award activity for the period is presented below:

 

     Non-vested
Number of
Shares
    Weighted
Average Grant-
Date Fair Value

Nonvested balance at December 31, 2007

   382,230     $ 18.28

Awarded

   400,840       22.82

Vested

   (102,100 )     18.67

Forfeited

   (72,468 )     20.94
            

Nonvested balance at September 30, 2008

   608,502     $ 20.89
            

As of September 30, 2008, $9.6 million of total unrecognized compensation costs related to non-vested stock awards is expected to be recognized over a weighted average period of 2.3 years.

 

13


Table of Contents

ECLIPSYS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

This excerpt taken from the ECLP 10-Q filed Aug 7, 2008.

Non-Vested Restricted Stock

Non-vested restricted stock is sometimes granted by the Company. The restrictions lapse on a pro rata basis over a specified period of time, generally four to five years. The grant date fair value per share of non-vested restricted stock, which is the stock price on the grant date, is expensed on a straight-line basis over the period during which the restrictions lapse. The shares represented by restricted stock awards are considered outstanding at the grant date, as the recipients are entitled to dividends and voting rights. A summary of restricted stock award activity for the period is presented below:

 

     Non-vested
Number of
Shares
    Weighted
Average Grant-
Date Fair Value

Nonvested balance at December 31, 2007

   382,230     $ 18.28

Awarded

   384,175       22.81

Vested

   (81,267 )     18.33

Forfeited

   (9,497 )     24.71
            

Nonvested balance at June 30, 2008

   675,641     $ 20.76
            

As of June 30, 2008, $12.4 million of total unrecognized compensation costs related to non-vested stock awards is expected to be recognized over a weighted average period of 2.7 years.

This excerpt taken from the ECLP 10-Q filed May 12, 2008.

Non-Vested Restricted Stock

Non-vested restricted stock is sometimes granted under the plans. The restrictions lapse on a pro rata basis over a specified period of time, generally four to five years. The grant date fair value per share of non-vested restricted stock, which is the stock price on the grant date, is expensed on a straight-line basis over the period during which the restrictions lapse. The shares represented by restricted

 

12


Table of Contents

ECLIPSYS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Thousands, Except Share and Per Share Amounts and as Otherwise Indicated)

(Unaudited)

 

stock awards are considered outstanding at the grant date, as the recipients are entitled to dividends and voting rights. A summary of restricted stock award activity under the plans is presented below:

 

     Non-vested
Number of
Shares
    Weighted
Average Grant-
Date Fair Value

Nonvested balance at December 31, 2007

   382,230     $ 18.28

Awarded

   384,175       22.81

Vested

   —         —  

Forfeited

   (2,742 )     24.71
        

Nonvested balance at March 31, 2008

   763,663     $ 20.53
        

As of March 31, 2008, $13.2 million of total unrecognized compensation costs related to non-vested stock awards is expected to be recognized over a weighted average period of 2.9 years.

This excerpt taken from the ECLP 10-K filed Feb 29, 2008.

Non-Vested Restricted Stock

From time to time the Company has issued non-vested restricted stock grants to members of senior management. The Company issued 150,000 and 100,000 shares in 2007 and 2006, respectively. Generally, restricted stock grants vest over a five-year period.

Non-vested restricted stock award activity for the year ended December 31, 2007 is summarized as follows:

 

     Non-vested
Number of Shares
    Weighted
Average Grant -
Date Fair Value

Nonvested balance at January 1, 2007

   366,128     $ 17.29

Granted

   150,000     $ 19.62

Vested

   (124,033 )   $ 17.23

Forfeited

   (9,865 )   $ 15.11
        

Nonvested balance at December 31, 2007

   382,230     $ 18.28
        

Compensation expense for non-vested restricted common stock issued at discounted prices is recognized over the vesting period for the difference between the purchase price and the fair market value on the measurement date. Compensation expense recorded for stock-based awards of restricted stock was $2.3 million, $2.6 million, and $2.4 million, for the years ended December 31, 2007, 2006 and 2005, respectively.

As of December 31, 2007, $6.1 million of total unrecognized compensation costs related to non-vested restricted awards is expected to be recognized over a weighted average period of 3.19 years. The fair value of shares vested in each of the years ended December 31, 2007, 2006 and 2005 was $2.7 million, $6.0 million and $0.8 million, respectively.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki